The high percentages of circulating PD-1+CD8+ T and PD-1+CD8+ Tm as well as PD-1+CD8+T/PD-1+CD4+T cell ratio at the baseline were significantly associated with good prognoses in advanced gastric cancer patients treated with ICI therapy plus chemotherapy. Here, PDCD1 is linked to gastric cancer.